author

Dr. Ajit Kumar

Dr. Ajit Kumar is a health educator, medical content reviewer, and founder of Medimadad, an evidence-based health education platform. He holds an MD (Medicine) degree and an MA (Psychology), bringing together medical knowledge and behavioral science to promote informed health decisions. His areas of focus include diabetes and metabolic health, men's health and sexual wellness, preventive healthcare, healthy aging, health psychology, and public health education. Through Medimadad, he is committed to improving health literacy by translating complex medical information into practical, accessible, and evidence-based educational content. Dr. Kumar is passionate about leveraging technology, digital health tools, and public health communication to empower individuals to make informed choices for long-term health and well-being.

What Is GIP and Why Does Mounjaro Target It Too? The Science Behind Tirzepatide’s Extra Power

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy When tirzepatide (Mounjaro/Zepbound) was approved, it was described as a dual GLP-1/GIP receptor agonist. Most of the attention went to GLP-1 – the hormone semaglutide (Ozempic) also targets, and the one that has dominated obesity medicine […]

Ashwagandha vs Creatine for Stress and Cognitive Performance: What the Research Actually Shows

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Walk into any supplement shop and you will find both ashwagandha and creatine on the shelves – often marketed for completely different purposes. Ashwagandha is positioned as a stress and anxiety supplement. Creatine is positioned as […]

Sleep Apnea and Weight Loss: Does Losing Weight Actually Fix Sleep Apnea?

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Sleep apnea affects an estimated 100 million people worldwide, and India carries a disproportionate burden – with obesity, anatomical factors, and underdiagnosis creating a perfect storm. The standard treatment, CPAP therapy, is effective but poorly tolerated: […]

Tirzepatide vs Semaglutide: Which Weight Loss Drug Is Right for You?

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For the first time in obesity medicine, doctors have two genuinely different classes of injectable weight loss drugs to choose from. Semaglutide (Ozempic/Wegovy) targets one hormone receptor; tirzepatide (Mounjaro/Zepbound) targets two, and produces meaningfully greater average […]

About UsContact UsMedical DisclaimerEditorial PolicyAffiliate DisclosureTerms & ConditionsCookie PolicyDisclaimerPrivacy Policy